BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26376857)

  • 1. Mutation in the Monocarboxylate Transporter 12 Gene Affects Guanidinoacetate Excretion but Does Not Cause Glucosuria.
    Dhayat N; Simonin A; Anderegg M; Pathare G; Lüscher BP; Deisl C; Albano G; Mordasini D; Hediger MA; Surbek DV; Vogt B; Sass JO; Kloeckener-Gruissem B; Fuster DG
    J Am Soc Nephrol; 2016 May; 27(5):1426-36. PubMed ID: 26376857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocarboxylate transporter 12 as a guanidinoacetate efflux transporter in renal proximal tubular epithelial cells.
    Jomura R; Tanno Y; Akanuma SI; Kubo Y; Tachikawa M; Hosoya KI
    Biochim Biophys Acta Biomembr; 2020 Nov; 1862(11):183434. PubMed ID: 32781157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solute carrier SLC16A12 is critical for creatine and guanidinoacetate handling in the kidney.
    Verouti SN; Lambert D; Mathis D; Pathare G; Escher G; Vogt B; Fuster DG
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F351-F358. PubMed ID: 33459166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cataract and glucosuria associated monocarboxylate transporter MCT12 is a new creatine transporter.
    Abplanalp J; Laczko E; Philp NJ; Neidhardt J; Zuercher J; Braun P; Schorderet DF; Munier FL; Verrey F; Berger W; Camargo SM; Kloeckener-Gruissem B
    Hum Mol Genet; 2013 Aug; 22(16):3218-26. PubMed ID: 23578822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile cataract-associated mutation of solute carrier SLC16A12 impairs trafficking of the protein to the plasma membrane.
    Castorino JJ; Gallagher-Colombo SM; Levin AV; Fitzgerald PG; Polishook J; Kloeckener-Gruissem B; Ostertag E; Philp NJ
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6774-84. PubMed ID: 21778275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing mechanism of guanidinoacetate in choroid plexus epithelial cells: conversion of guanidinoacetate to creatine via guanidinoacetate N-methyltransferase and monocarboxylate transporter 12-mediated creatine release into the CSF.
    Jomura R; Akanuma SI; Kubo Y; Tachikawa M; Hosoya KI
    Fluids Barriers CNS; 2022 Jun; 19(1):42. PubMed ID: 35658878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of monocarboxylate transporter 12 (SLC16A12/MCT12) as a facilitative creatine transporter.
    Takahashi M; Kishimoto H; Shirasaka Y; Inoue K
    Drug Metab Pharmacokinet; 2020 Jun; 35(3):281-287. PubMed ID: 32249133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of monocarboxylate transporter 12 to blood supply of creatine on the sinusoidal membrane of the hepatocytes.
    Jomura R; Tanno Y; Akanuma SI; Kubo Y; Tachikawa M; Hosoya KI
    Am J Physiol Gastrointest Liver Physiol; 2021 Aug; 321(2):G113-G122. PubMed ID: 34075817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal creatine transport of mutations in monocarboxylate transporter 12 (MCT12) found in patients with age-related cataract can be partially rescued by exogenous chaperone CD147.
    Stäubli A; Capatina N; Fuhrer Y; Munier FL; Labs S; Schorderet DF; Tiwari A; Verrey F; Heon E; Cheng CY; Wong TY; Berger W; Camargo SMR; Kloeckener-Gruissem B
    Hum Mol Genet; 2017 Nov; 26(21):4203-4214. PubMed ID: 29088427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel missense mutation in SLC5A2 encoding SGLT2 underlies autosomal-recessive renal glucosuria and aminoaciduria.
    Magen D; Sprecher E; Zelikovic I; Skorecki K
    Kidney Int; 2005 Jan; 67(1):34-41. PubMed ID: 15610225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLC6A and SLC16A family of transporters: Contribution to transport of creatine and creatine precursors in creatine biosynthesis and distribution.
    Jomura R; Akanuma SI; Tachikawa M; Hosoya KI
    Biochim Biophys Acta Biomembr; 2022 Mar; 1864(3):183840. PubMed ID: 34921896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of solute carrier SLC16A12 associates with a syndrome combining juvenile cataract with microcornea and renal glucosuria.
    Kloeckener-Gruissem B; Vandekerckhove K; Nürnberg G; Neidhardt J; Zeitz C; Nürnberg P; Schipper I; Berger W
    Am J Hum Genet; 2008 Mar; 82(3):772-9. PubMed ID: 18304496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLC5A2 mutations, including two novel mutations, responsible for renal glucosuria in Chinese families.
    Yu L; Wu M; Hou P; Zhang H
    BMC Nephrol; 2020 Feb; 21(1):69. PubMed ID: 32111189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis and literature review of Chinese patients with familial renal glucosuria: Identification of a novel SLC5A2 mutation.
    Wang X; Yu M; Wang T; Zhang H; Ping F; Zhang Q; Xu J; Feng K; Xiao X
    Clin Chim Acta; 2017 Jun; 469():105-110. PubMed ID: 28365451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal expression and dysfunction of novel SGLT2 mutations identified in familial renal glucosuria patients.
    Yu L; Lv JC; Zhou XJ; Zhu L; Hou P; Zhang H
    Hum Genet; 2011 Mar; 129(3):335-44. PubMed ID: 21165652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2).
    van den Heuvel LP; Assink K; Willemsen M; Monnens L
    Hum Genet; 2002 Dec; 111(6):544-7. PubMed ID: 12436245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial renal glucosuria: SLC5A2 mutation analysis and evidence of salt-wasting.
    Calado J; Loeffler J; Sakallioglu O; Gok F; Lhotta K; Barata J; Rueff J
    Kidney Int; 2006 Mar; 69(5):852-5. PubMed ID: 16518345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2.
    Coady MJ; El Tarazi A; Santer R; Bissonnette P; Sasseville LJ; Calado J; Lussier Y; Dumayne C; Bichet DG; Lapointe JY
    J Am Soc Nephrol; 2017 Jan; 28(1):85-93. PubMed ID: 27288013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression and function of sodium-glucose co-transporter 2 from a novel C-terminal mutation: a case report.
    Yu L; Xu Q; Hou P; Zhang H
    BMC Nephrol; 2016 Mar; 17():31. PubMed ID: 27000029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic anion transporter OAT3 enhances the glucosuric effect of the SGLT2 inhibitor empagliflozin.
    Fu Y; Breljak D; Onishi A; Batz F; Patel R; Huang W; Song P; Freeman B; Mayoux E; Koepsell H; Anzai N; Nigam SK; Sabolic I; Vallon V
    Am J Physiol Renal Physiol; 2018 Aug; 315(2):F386-F394. PubMed ID: 29412698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.